These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10592954)

  • 1. Role of US poison centers in adverse drug reactions monitoring.
    Chyka PA
    Vet Hum Toxicol; 1999 Dec; 41(6):400-2. PubMed ID: 10592954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The state of dietary supplement adverse event reporting in the United States.
    Gardiner P; Sarma DN; Low Dog T; Barrett ML; Chavez ML; Ko R; Mahady GB; Marles RJ; Pellicore LS; Giancaspro GI
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):962-70. PubMed ID: 18613260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting of adverse drug reactions by poison control centres in the US.
    Chyka PA; McCommon SW
    Drug Saf; 2000 Jul; 23(1):87-93. PubMed ID: 10915034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the quality of adverse drug reaction reporting by 4th-year medical students.
    Rosebraugh CJ; Tsong Y; Zhou F; Chen M; Mackey AC; Flowers C; Toyer D; Flockhart DA; Honig PK
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):97-101. PubMed ID: 12642973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of US poison centers: a 1998 survey conducted by the American Association of Poison Control Centers.
    Youniss J; Litovitz T; Villanueva P
    Vet Hum Toxicol; 2000 Feb; 42(1):43-53. PubMed ID: 10670088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM; Bortnichak EA
    Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving adverse drug reaction reporting in the community setting.
    McCloskey BA
    Med Interface; 1996 May; 9(5):85-7. PubMed ID: 10157690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognizing and reporting adverse drug reactions.
    Lucas LM; Colley CA
    West J Med; 1992 Feb; 156(2):172-5. PubMed ID: 1536067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control charts to monitor rates of adverse drug reactions.
    Schumock GT; Seeger JD; Kong SX
    Hosp Pharm; 1995 Dec; 30(12):1088, 1091-2, 1095-6. PubMed ID: 10153656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine.
    Spiller HA; Griffith JR; Anderson DL; Weber JA; Aleguas A
    Ann Pharmacother; 2008 Jul; 42(7):1142-3. PubMed ID: 18594051
    [No Abstract]   [Full Text] [Related]  

  • 13. Causes of therapeutic errors in older adults: evaluation of National Poison Center data.
    Hayes BD; Klein-Schwartz W; Gonzales LF
    J Am Geriatr Soc; 2009 Apr; 57(4):653-8. PubMed ID: 19220563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA announces MedWatch: a new reporting program for health professionals.
    Hopkinson SE
    AANA J; 1993 Aug; 61(4):373-8. PubMed ID: 8379285
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases.
    Coté TR; Mohan AK; Polder JA; Walton MK; Braun MM
    J Am Acad Dermatol; 2005 Sep; 53(3):407-15. PubMed ID: 16112345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult glyburide ingestions reported to Texas poison control centers, 1998 2005.
    Forrester MB
    Hum Exp Toxicol; 2007 Jul; 26(7):563-71. PubMed ID: 17884959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for drug and poison information--the Singapore physicians' perspective.
    Ponampalam R; Anantharaman V
    Singapore Med J; 2003 May; 44(5):231-42. PubMed ID: 13677359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.